Longitudinal analysis of neuropsychiatric symptoms in a large cohort of early-moderate manifest Huntington's disease patients

被引:9
|
作者
Ruiz-Idiago, Jesus [1 ,2 ,3 ,4 ,6 ]
Pomarol-Clotet, Edith [4 ,5 ]
Salvador, Raymond [4 ,5 ]
机构
[1] Hermanas Hosp, Hosp Mare Deu Merce, Neuropsychiat Unit, Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Psychiat & Forens Med, Barcelona, Spain
[3] European Huntingtons Dis Network EHDN, Ulm, Germany
[4] FIDMAG Germanes Hospitalaries Res Fdn, Barcelona, Spain
[5] Mental Hlth Res Networking Ctr CIBERSAM, Madrid, Spain
[6] Neuropsychiat Unit, Avda Jorda 10, Barcelona 08035, Spain
关键词
Huntington?s disease; Neuropsychiatric symptoms; Longitudinal studies; Apathy; Irritability; Perseveration; PROBLEM BEHAVIORS ASSESSMENT; FUNCTIONAL DECLINE; SUICIDAL IDEATION; PBA-S; RELIABILITY;
D O I
10.1016/j.parkreldis.2022.11.020
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The relationship between neuropsychiatric symptoms (NPS) and other clinical dimensions in Huntington's disease (HD) is controversial. This longitudinal study analyzed the association between NPS and motor, cognitive and functional aspects of the disease along with other variables related to its clinical onset and progression.Methods: 639 early-moderate HD patients were assessed longitudinally (mean: 4.95 visits/5 years). Generalized linear mixed models were used to explore associations between NPS and the aforementioned aspects. Other variables previously reported as significant in smaller or cross-sectional studies were included in the models.Results: Significant associations found included a negative linear relationship between presence of depressed mood and illness duration (7.2% odds reduction of being depressed per year), a 7.6% increase in the odds of having irritability with increased chorea scores, a negative association (4.3% reduction in odds) between age at onset and aggression (i.e. earlier onset was related to a higher probability of having aggressive behaviors) and a negative association between irritability and the interference component of the Stroop test (3% odds change). Total functional capacity (TFC) was the most frequently associated factor with NPS, with apathy and persev-erative behavior having the strongest relations with TFC (22% and 18% increases in odds per unit reduction in TFC respectively).Conclusions: With the exception of irritability, NPS are not related to motor or cognitive variables in early -moderate HD. Total functional capacity (TFC) is the most frequently associated factor with NPS, with apathy and perseverative behavior having the strongest relations with TFC.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease
    Aarsland, D.
    Bronnick, K.
    Alves, G.
    Tysnes, O. B.
    Pedersen, K. F.
    Ehrt, U.
    Larsen, J. P.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (08): : 928 - 930
  • [22] Neuropsychiatric Symptoms in Patients with Early Parkinson's Disease in the Mexican Population
    Arredondo Blanco, Kenia
    Julissa Rodriguez, Rosaura
    Ospina Garcia, Natalia
    Perez-Lohman, Christian
    Diego Vargas-Jaramillo, Juan
    Zeron-Martinez, Rosalia
    De La Cruz-Landeros, Alejandra
    Gonzalez-Hernanez, Vanessa
    Rodriguez Violante, Mayela
    Cervantes-Arriaga, Amin
    MOVEMENT DISORDERS, 2018, 33 : S107 - S108
  • [23] Deep rTMS for Neuropsychiatric Symptoms of Huntington's Disease: Case Report
    Davis, Molly
    Phillips, Angela
    Tendler, Aron
    Oberdeck, Angela
    BRAIN STIMULATION, 2016, 9 (06) : 960 - 961
  • [24] Neuropsychiatric symptoms in huntington's disease-5 case series
    Vedean, M.
    Oleleu, A.
    Dragomir, I.
    Scarisoreanu, G.
    Marginean, C.
    EUROPEAN PSYCHIATRY, 2019, 56 : S357 - S358
  • [25] A Systematic Review of Neuropsychiatric Symptoms and Functional Capacity in Huntington's Disease
    Sellers, Jessie
    Ridner, Sheila H.
    Claassen, Daniel O.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2020, 32 (02) : 109 - 124
  • [26] Pharmacological Treatment of Neuropsychiatric Symptoms in Huntington's Disease: A Systematic Review
    Andriessen, Ruben L.
    Oosterloo, Mayke
    Molema, Jory
    Daemen, Maud M. J.
    Linden, David E. J.
    Leentjens, Albert F. G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2025,
  • [27] Lifetime neuropsychiatric symptoms in Huntington's disease: Implications for psychiatric nursing
    Gibson, Jessie S.
    Isaacs, David A.
    Claassen, Daniel O.
    Stovall, Jeffrey G.
    ARCHIVES OF PSYCHIATRIC NURSING, 2021, 35 (03) : 284 - 289
  • [28] Neuropsychiatric Symptoms and Syndromes in a Large Cohort of Newly Diagnosed, Untreated Patients With Alzheimer Disease
    Spalletta, Gianfranco
    Musicco, Massimo
    Padovani, Alesandro
    Rozzini, Luca
    Perri, Roberta
    Fadda, Lucia
    Canonico, Vincenzo
    Trequattrini, Alberto
    Pettenati, Carla
    Caltagirone, Carlo
    Palmer, Katie
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 18 (11): : 1026 - 1035
  • [29] Striatal hypometabolism in premanifest and manifest Huntington's disease patients
    Alfonso Lopez-Mora, Diego
    Camacho, Valle
    Perez-Perez, Jesus
    Martinez-Horta, Saul
    Fernandez, Alejandro
    Sampedro, Frederic
    Montes, Alberto
    Andrea Lozano-Martinez, Gloria
    Gomez-Anson, Beatriz
    Kulisevsky, Jaime
    Carrio, Ignasi
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (12) : 2183 - 2189
  • [30] Longitudinal changes in volume and shape of striatal nuclei in manifest Huntington's disease
    de Langavant, L. Cleret
    Nazir, M.
    Gaura, V.
    Lavisse, S.
    Verny, C.
    Krystkowiak, P.
    Bachoud-Levi, A-C
    Remy, P.
    MOVEMENT DISORDERS, 2014, 29 : S206 - S206